Boston Scis new pain-management product gets go-ahead
The FDA has okayed Boston Scientific’s new percutaneous lead for use with the company’s Precision Plus rechargeable spinal-cord stimulator, which is used to manage chronic pain.
The new lead, called the Infinion 16, can send up to 16 electrical pulses from an implantable pulse generator to the spinal cord, according to the company. The jolts interrupt pain signals before they can reach the brain. Previous iterations of the technology provided a maximum of eight contacts from each lead.
According to the American Pain Foundation, chronic pain affects more than 75 million Americans.
The new lead, called the Infinion 16, can send up to 16 electrical pulses from an implantable pulse generator to the spinal cord, according to the company. The jolts interrupt pain signals before they can reach the brain. Previous iterations of the technology provided a maximum of eight contacts from each lead.
According to the American Pain Foundation, chronic pain affects more than 75 million Americans.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.